Article
Early memory phenotypes drive T cell proliferation in patients with pediatric malignancies.
Science translational medicine - 6 Jan 2016
Singh Nathan, Perazzelli Jessica, Grupp Stephan A, Barrett David M
Abstract excerpt
Engineered T cell therapies have begun to demonstrate impressive clinical responses in patients with B cell malignancies. Despite this efficacy, many patients are unable to receive T cell therapy because of failure of in vitro expansion, a necessary component of cell manufacture and a predictor of in vivo activity. To evaluate the biology underlying these functional differences, we investigated T cell expansion...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
